HealthStream (HSTM) 10-Q 31 Jul 20 2020 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2020	Jul. 24, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Trading Symbol	HSTM
Entity Registrant Name	HealthStream, Inc.
Entity Central Index Key	0001095565
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		31,997,499
Entity Shell Company	false
Entity File Number	000-27701
Entity Tax Identification Number	62-1443555
Entity Address, Address Line One	500 11th Avenue North
Entity Address, Address Line Two	Suite 1000
Entity Address, City or Town	Nashville
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37203
City Area Code	615
Local Phone Number	301-3100
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	TN
Document Quarterly Report	true
Document Transition Report	false
Title of 12(b) Security	Common Stock (Par Value $0.00)
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 112,534	$ 131,538
Marketable securities	31,989	41,328
Accounts receivable, net of allowance for doubtful accounts of $855 and $843 at June 30, 2020 and December 31, 2019, respectively	30,621	27,650
Accounts receivable - unbilled	3,244	2,726
Prepaid royalties, net of amortization	11,323	11,898
Other prepaid expenses and other current assets	8,969	9,432
Total current assets	198,680	224,572
Property and equipment, net of accumulated depreciation of $22,865 and $19,291 at June 30, 2020 and December 31, 2019, respectively	22,936	26,065
Capitalized software development, net of accumulated amortization of $63,796 and $57,768 at June 30, 2020 and December 31, 2019, respectively	23,250	21,445
Operating lease right of use assets, net	28,422	29,615
Goodwill	123,285	102,196
Deferred tax assets	269	269
Deferred commissions	17,024	17,645
Non-marketable equity investments	6,590	6,782
Other assets	441	874
Total assets	477,825	489,544
Current liabilities:
Accounts payable and accrued expenses	17,422	22,938
Accrued royalties	8,894	16,736
Deferred revenue	66,126	65,511
Total current liabilities	92,442	105,185
Deferred tax liabilities	13,491	13,183
Deferred revenue, noncurrent	1,609	1,918
Operating lease liability, noncurrent	29,388	30,733
Other long term liabilities	1,471	357
Commitments and contingencies
Shareholders’ equity:
Common stock, no par value, 75,000 shares authorized; 31,997 and 32,379 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively	280,746	290,021
Retained earnings	58,677	48,143
Accumulated other comprehensive income	1	4
Total shareholders’ equity	339,424	338,168
Total liabilities and shareholders’ equity	477,825	489,544
Customer-Related Intangible Assets [Member]
Current assets:
Intangible assets, net	49,220	52,554
Other Intangible Assets [Member]
Current assets:
Intangible assets, net	$ 7,708	$ 7,527

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Allowance for doubtful accounts, net	$ 855	$ 843
Accumulated depreciation on property and equipment	22,865	19,291
Accumulated amortization on capitalized software development	$ 63,796	$ 57,768
Common stock, no par value
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	31,997,000	32,379,000
Common stock, shares outstanding	31,997,000	32,379,000
Customer-Related Intangible Assets [Member]
Accumulated amortization on intangible assets	$ 33,129	$ 29,760
Other Intangible Assets [Member]
Accumulated amortization on intangible assets	$ 14,363	$ 12,735

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Revenues, net	$ 60,553	$ 63,781	$ 122,125	$ 128,967
Operating costs and expenses:
Cost of revenues (excluding depreciation and amortization)	22,935	26,806	43,294	53,667
Product development	7,830	7,640	15,298	14,567
Sales and marketing	8,236	9,819	17,424	19,340
Other general and administrative expenses	10,098	10,306	19,963	20,276
Depreciation and amortization	7,150	6,942	14,599	13,480
Total operating costs and expenses	56,249	61,513	110,578	121,330
Operating income	4,304	2,268	11,547	7,637
Other income, net	199	852	1,906	1,674
Income from continuing operations before income tax provision	4,503	3,120	13,453	9,311
Income tax provision	1,061	719	2,920	2,130
Income from continuing operations	3,442	2,401	10,533	7,181
Gain on sale of discontinued operations				1,620
Income tax provision				426
Income from discontinued operations				1,194
Net income	$ 3,442	$ 2,401	$ 10,533	$ 8,375
Net income per share – basic:
Continuing operations	$ 0.11	$ 0.07	$ 0.33	$ 0.22
Discontinued operations				0.04
Net income per share - basic	0.11	0.07	0.33	0.26
Net income per share - diluted:
Continuing operations	0.11	0.07	0.33	0.22
Discontinued operations				0.04
Net income per share - diluted	$ 0.11	$ 0.07	$ 0.33	$ 0.26
Weighted average shares of common stock outstanding:
Basic	31,997	32,394	32,166	32,366
Diluted	32,025	32,434	32,191	32,406

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 3,442	$ 2,401	$ 10,533	$ 8,375
Other comprehensive income, net of taxes:
Foreign currency translation adjustments	17	4	(27)	3
Unrealized gain on marketable securities	125	10	24	43
Total other comprehensive income (loss)	142	14	(3)	46
Comprehensive income	$ 3,584	$ 2,415	$ 10,530	$ 8,421

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive (Loss) Income [Member]
Beginning balance at Dec. 31, 2018	$ 318,947	$ 286,597	$ 32,373	$ (23)
Beginning balance, shares at Dec. 31, 2018		32,325,000
Net income	5,974		5,974
Comprehensive income (loss)	32			32
Stock based compensation	516	$ 516
Common stock issued under stock plans, net of shares withheld for employee taxes	(328)	$ (328)
Common stock issued under stock plans, net of shares withheld for employee taxes, shares		63,000
Ending balance at Mar. 31, 2019	325,141	$ 286,785	38,347	9
Ending balance, shares at Mar. 31, 2019		32,388,000
Beginning balance at Dec. 31, 2018	318,947	$ 286,597	32,373	(23)
Beginning balance, shares at Dec. 31, 2018		32,325,000
Net income	8,375
Comprehensive income (loss)	46
Ending balance at Jun. 30, 2019	329,671	$ 288,900	40,748	23
Ending balance, shares at Jun. 30, 2019		32,374,000
Beginning balance at Mar. 31, 2019	325,141	$ 286,785	38,347	9
Beginning balance, shares at Mar. 31, 2019		32,388,000
Net income	2,401		2,401
Comprehensive income (loss)	14			14
Stock donated to Company (held in treasury), shares		(86,000)
Stock based compensation	2,558	$ 2,558
Common stock issued under stock plans, net of shares withheld for employee taxes	(443)	$ (443)
Common stock issued under stock plans, net of shares withheld for employee taxes, shares		72,000
Ending balance at Jun. 30, 2019	329,671	$ 288,900	40,748	23
Ending balance, shares at Jun. 30, 2019		32,374,000
Beginning balance at Dec. 31, 2019	$ 338,168	$ 290,021	48,143	4
Beginning balance, shares at Dec. 31, 2019	32,379,000	32,379,000
Net income	$ 7,092		7,092
Comprehensive income (loss)	(145)			(145)
Stock based compensation	550	$ 550
Common stock issued under stock plans, net of shares withheld for employee taxes	(373)	$ (373)
Common stock issued under stock plans, net of shares withheld for employee taxes, shares		62,000
Repurchase of common stock	(9,876)	$ (9,876)
Repurchase of common stock, shares		(438,000)
Ending balance at Mar. 31, 2020	335,416	$ 280,322	55,235	(141)
Ending balance, shares at Mar. 31, 2020		32,003,000
Beginning balance at Dec. 31, 2019	$ 338,168	$ 290,021	48,143	4
Beginning balance, shares at Dec. 31, 2019	32,379,000	32,379,000
Net income	$ 10,533
Comprehensive income (loss)	(3)
Repurchase of common stock	$ (10,000)
Repurchase of common stock, shares	(443,941)
Ending balance at Jun. 30, 2020	$ 339,424	$ 280,746	58,677	1
Ending balance, shares at Jun. 30, 2020	31,997,000	31,997,000
Beginning balance at Mar. 31, 2020	$ 335,416	$ 280,322	55,235	(141)
Beginning balance, shares at Mar. 31, 2020		32,003,000
Net income	3,442		3,442
Comprehensive income (loss)	142			142
Stock based compensation	557	$ 557
Repurchase of common stock	$ (133)	$ (133)
Repurchase of common stock, shares	(5,799)	(6,000)
Ending balance at Jun. 30, 2020	$ 339,424	$ 280,746	$ 58,677	$ 1
Ending balance, shares at Jun. 30, 2020	31,997,000	31,997,000

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2018
OPERATING ACTIVITIES:
Net income			$ 10,533	$ 8,375
Income from discontinued operations				(1,194)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	$ 7,150	$ 6,942	14,599	13,480
Stock based compensation			1,107	3,074
Amortization of deferred commissions	2,100	2,100	4,254	4,201
Provision for doubtful accounts			351	48
Deferred income taxes			2,427	2,066
Loss (gain) on non-marketable equity investments			50	(69)
Non-cash royalty expense			(3,440)
Change in fair value of non-marketable equity investments			(1,181)		$ 1,300
Other			121	(84)
Changes in operating assets and liabilities:
Accounts and unbilled receivables			(3,759)	12,019
Prepaid royalties			576	1,626
Other prepaid expenses and other current assets			547	2,746
Deferred commissions			(3,634)	(3,265)
Other assets			505	(391)
Accounts payable and accrued expenses			(5,167)	(4,060)
Accrued royalties			(4,588)	(2,294)
Deferred revenue			231	329
Net cash provided by operating activities			13,532	36,607
INVESTING ACTIVITIES:
Business combinations, net of cash acquired			(21,449)	(18,018)
Proceeds from sale of discontinued operations				6,222
Proceeds from maturities of marketable securities			46,183	38,037
Purchases of marketable securities			(36,942)	(44,158)
Proceeds from sale of property and equipment				12
Payments to acquire non-marketable equity investments			(1,000)	(3,342)
Payments associated with capitalized software development			(7,619)	(8,374)
Purchases of property and equipment			(1,268)	(19,598)
Net cash used in investing activities			(22,095)	(49,219)
FINANCING ACTIVITIES:
Proceeds from exercise of stock options				214
Taxes paid related to net settlement of equity awards			(373)	(985)
Payments of earn-outs related to acquisitions				(37)
Repurchases of common stock			(10,009)
Payment of cash dividends			(31)	(52)
Net cash used in financing activities			(10,413)	(860)
Effect of exchange rate changes on cash and cash equivalents			(28)
Net decrease in cash and cash equivalents			(19,004)	(13,472)
Cash and cash equivalents at beginning of period			131,538	134,321
Cash and cash equivalents at end of period	$ 112,534	$ 120,849	112,534	$ 120,849	$ 134,321
SUPPLEMENTAL CASH FLOW INFORMATION:
Non-cash additions to non-marketable equity investments			$ 1,300

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	1. BASIS OF PRESENTATION The accompanying Condensed Consolidated Financial Statements (unaudited) have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) for interim financial information and with the instructions to Form 10‑Q and Article 10 of Regulation S‑X. Accordingly, Condensed Consolidated Financial Statements do not include all information and footnotes required by US GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. All intercompany transactions have been eliminated in consolidation. Operating results for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. On February 12, 2018, the Company divested its Patient Experience (“PX”) business to Press Ganey Associates, Inc. (“Press Ganey”). The sale of the PX business resulted in the Company’s divestiture of the Company’s patient experience solutions business segment. The Company has classified the results of its previously owned PX segment as discontinued operations in its Condensed Consolidated Statement of Income for the six months ended June 30, 2019. See Note 10 for additional information. The Condensed Consolidated Balance Sheet at December 31, 2019 has been derived from the audited Consolidated Financial Statements at that date does not include all information and footnotes required by US GAAP for complete financial statements. For further information, refer to the Consolidated Financial Statements and footnotes thereto for the year ended December 31, 2019 (included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February 26, 2020).

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2020
Accounting Changes And Error Corrections [Abstract]
Recent Accounting Pronouncements	2. RECENT ACCOUNTING PRONOUNCEMENTS Accounting Standards Recently Adopted In June 2016, the FASB issued ASU 2016-03, Financial Instruments—Credit Losses (“ASC 326”): Measurement of Credit Losses on Financial Instruments

Revenue Recognition And Sales C

Revenue Recognition And Sales Commissions	6 Months Ended
	Jun. 30, 2020
Revenue From Contract With Customer [Abstract]
Revenue Recognition and Sales Commissions	3. REVENUE RECOGNITION AND SALES COMMISSIONS Revenue Recognition Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: • Identification of the contract with a customer • Identification of the performance obligations in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligations in the contract • Recognition of revenue when, or as, the Company satisfies a performance obligation The following table represents revenues disaggregated by revenue source for the three and six months ended June 30, 2020 and 2019 (in thousands). Sales taxes are excluded from revenues. Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Business Segments Workforce Solutions Provider Solutions Consolidated Workforce Solutions Provider Solutions Consolidated Subscription $ 47,981 $ 9,954 $ 57,935 $ 96,699 $ 19,581 $ 116,280 Professional services 907 1,711 2,618 2,013 3,832 5,845 Total revenues, net $ 48,888 $ 11,665 $ 60,553 $ 98,712 $ 23,413 $ 122,125 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Business Segments Workforce Solutions Provider Solutions Consolidated Workforce Solutions Provider Solutions Consolidated Subscription $ 50,892 $ 9,501 $ 60,393 $ 103,696 $ 18,581 $ 122,277 Professional services 1,530 1,858 3,388 3,020 3,670 6,690 Total revenues, net $ 52,422 $ 11,359 $ 63,781 $ 106,716 $ 22,251 $ 128,967 For the three months ended June 30, 2020 and 2019, the Company recognized $63,000 and $46,000 in impairment losses on receivables and contract assets arising from the Company’s contracts with customers, respectively. For the six months ended June 30, 2020 and 2019, the Company recognized $351,000 and $48,000 in impairment losses on receivables and contract assets arising from the Company’s contracts with customers, respectively. Deferred revenue represents contract liabilities that are recorded when cash payments are received or are due in advance of our satisfaction of performance obligations. During the three months ended June 30, 2020 and 2019, we recognized $35.2 million and $36.3 million of revenue from amounts included in deferred revenues at the beginning of the respective periods. During the six months ended June 30, 2020 and 2019, we recognized $49.9 million and $51.2 million of revenue from amounts included in deferred revenues at the beginning of the respective periods. As of June 30, 2020, $380 million of revenue is expected to be recognized from remaining performance obligations under contract with customers. We expect to recognize revenue with respect to 45% of these remaining performance obligations over the next 12 months, with the remaining amounts recognized thereafter. Sales Commissions Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The sales commission plan for 2020 typically includes two payments; the initial payment is due in the period a customer contract is entered into, and the final payment is due 60 days after the product implementation is completed. The sales commission plan for 2019 typically included an initial payment in the period a customer contract was entered into, and subsequent payments either 15 or 27 months after the initial payment, depending on the contract term. Non-commensurate commissions are amortized over the greater of the contract term or technological obsolescence period of approximately three years.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	4. INCOME TAXES Income taxes are accounted for using the asset and liability method, whereby deferred tax assets and liabilities are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities measured at tax rates that will be in effect for the year in which the differences are expected to affect taxable income. During the three months ended June 30, 2020 and 2019 six months ended June 30, 2020 and 2019 six months ended June 30, 2020 and 2019

Shareholders' Equity

Shareholders' Equity	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Shareholders' Equity	5. SHAREHOLDERS’ EQUITY Stock Based Compensation The Company has stock awards outstanding under its 2016 Omnibus Incentive Plan. The Company accounts for its stock based compensation plans using the fair-value based method for costs related to share based payments, including restricted share units (“RSUs”). During the six months ended June 30, 2020, the Company issued 111,510 RSUs, subject to service-based time vesting, with a weighted average grant date fair value of $22.96 per share measured based on the closing fair market value of the Company’s stock on the date of grant. During the six months ended June 30, 2019, the Company issued 86,220 RSUs, subject to service-based time vesting, with a weighted average grant date fair value of $27.39 per share measured based on the closing fair market value of the Company’s stock on the date of grant. Total stock based compensation expense recorded for the three and six months ended June 30, 2020 and 2019, which is recorded within continuing operations in the Condensed Consolidated Statements of Income, is as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Cost of revenues (excluding depreciation and amortization) $ 16 $ 670 $ 23 $ 671 Product development 93 765 173 818 Sales and marketing 60 462 110 518 Other general and administrative 388 661 801 1,067 Total stock based compensation expense $ 557 $ 2,558 $ 1,107 $ 3,074 Share Repurchase Plan On March 13, 2020, the Company’s Board of Directors authorized a share repurchase program to repurchase up to $30.0 million of outstanding shares of common stock. The share repurchase program will terminate on the earlier of March 12, 2021 or when the maximum dollar amount has been expended. Pursuant to this authorization, repurchases have been made, and may continue to be made from time to time, in the open market through privately negotiated transactions or otherwise, including under a Rule 10b5-1 plan, which permits shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws in accordance with specific prearranged terms related to timing, price, and volume (among others), without further direction from the Company. The share repurchase program does not require the Company to acquire any amount of shares and may be suspended or discontinued at any time. Under this program during the three months ended June 30, 2020, the Company repurchased 5,799 shares at an aggregate fair value of $0.1 million, reflecting an average price per share of $22.87 (excluding the cost of dealer commissions). During the six months ended June 30, 2020, the Company repurchased 443,941 shares at an aggregate fair value of $10.0 million, reflecting an average price per share of $22.53 (excluding the cost of broker commissions) . Stock Awards During June 2019, the Company’s Chief Executive Officer, Robert A. Frist, Jr., contributed 78,520 of his personally owned shares of HealthStream, Inc. common stock (valued at $2.0 million) to the Company, without any consideration paid to him, for the benefit of the Company’s employees. In connection therewith, effective June 26, 2019 the Company approved the award of 78,520 fully vested shares of common stock to approximately 820 employees of the Company under the HealthStream, Inc. 2016 Omnibus Incentive Plan. These shares were issued in July 2019. As required by ASC Topic 718, Compensation – Stock Compensation , the Company recognized $ 2.0 million of stock based compensation expense for these stock awards during the three months ended June 30, 2019 based on the closing fair market value of the Company’s stock on the date of the Company’s approval of these grants. Total payments related to the employees’ tax obligations to taxing authorities for these stock awards were $ 0.6 million and are reflected as a financing activity within the Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2019. In addition, the employer taxes and expenses associated with these grants were $ 0.2 million and were recorded as an expense during June 2019. Mr. Frist contributed an additional 7,852 of his personally owned shares to cover these costs. The receipt of shares from Mr. Frist and in connection with the withholding of shares as set forth above are presented on the Company’s Condensed Consolidated Statement s of Shareholders’ Equity in a similar manner as a share repurchase (i.e., reduction of outstanding shares ) .

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share	6. EARNINGS PER SHARE Basic earnings per share is computed by dividing the net income available to common shareholders for the period by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing the net income available to common shareholders for the period by the weighted average number of potentially dilutive common and common equivalent shares outstanding during the period. Common equivalent shares are composed of incremental common shares issuable in connection with RSUs subject to vesting. The dilutive effect of common equivalent shares is included in diluted earnings per share by application of the treasury stock method. The total number of common equivalent shares excluded from the calculations of diluted earnings per share due to their anti-dilutive effect or contingent performance conditions was 108,000 and 131,000 for the three months ended June 30, 2020 and 2019 six months ended June 30, 2020 and 2019 The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2020 and 2019 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Numerator: Income from continuing operations $ 3,442 $ 2,401 $ 10,533 $ 7,181 Income from discontinued operations — — — 1,194 Net income $ 3,442 $ 2,401 $ 10,533 $ 8,375 Denominator: Weighted-average shares outstanding 31,997 32,394 32,166 32,366 Effect of dilutive shares 28 40 25 40 Weighted-average diluted shares 32,025 32,434 32,191 32,406 Net income per share - basic: Continuing operations $ 0.11 $ 0.07 $ 0.33 $ 0.22 Discontinued operations — — — 0.04 Net income per share - basic $ 0.11 $ 0.07 $ 0.33 $ 0.26 Net income per share - diluted: Continuing operations $ 0.11 $ 0.07 $ 0.33 $ 0.22 Discontinued operations — — — 0.04 Net income per share - diluted $ 0.11 $ 0.07 $ 0.33 $ 0.26

Marketable Securities

Marketable Securities	6 Months Ended
	Jun. 30, 2020
Investments Debt And Equity Securities [Abstract]
Marketable Securities	7. MARKETABLE SECURITIES At June 30, 2020 and December 31, 2019, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands): June 30, 2020 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Level 2: Corporate debt securities $ 31,965 $ 36 $ (12 ) $ 31,989 Total $ 31,965 $ 36 $ (12 ) $ 31,989 December 31, 2019 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Level 2: Corporate debt securities $ 37,325 $ 7 $ (5 ) $ 37,327 Government-sponsored enterprise debt securities 4,001 — — 4,001 Total $ 41,326 $ 7 $ (5 ) $ 41,328 The carrying amounts reported in the Condensed Consolidated Balance Sheets approximate the fair value based on quoted market prices or alternative pricing sources and models utilizing market observable inputs. As of June 30, 2020, the Company did not recognize any allowance for credit impairments on its available for sale debt securities. All investments in marketable securities are classified as current assets on the Condensed Consolidated Balance Sheets because the underlying securities mature within one year from the balance sheet date.

Business Combinations

Business Combinations	6 Months Ended
	Jun. 30, 2020
Business Combinations [Abstract]
Business Combinations	8. BUSINESS COMBINATIONS CredentialMyDoc On December 16, 2019, the Company acquired substantially all the assets of Covenant Technology Group, LLC (“CredentialMyDoc”), a Savannah, Georgia-based company focusing on intuitive, easy to use, and fast to implement software-as-a-service solution, primarily in ambulatory care settings. The consideration paid for CredentialMyDoc consisted of $9.0 million in cash, after giving effect to the post-closing working capital adjustment. Of the purchase price paid at closing, $1.1 million is being held in escrow for a period of time following the closing to serve as a source of recovery for the working capital adjustment and certain potential indemnification claims by the Company. The results of operations for CredentialMyDoc have been included in the Provider Solutions segment of the Company’s Financial Statements from the date of acquisition. A summary of the purchase price is as follows (in thousands): Cash paid at closing $ 9,000 Working capital adjustment - post-closing (5 ) Total consideration paid $ 8,995 The following table summarizes the fair value of the assets acquired and liabilities assumed as of the date of acquisition (in thousands): Accounts and unbilled receivable, net $ 204 Prepaid and other current assets 3 Operating lease right-of-use assets 30 Deferred tax assets 70 Goodwill 4,661 Intangible assets 4,340 Accounts payable and accrued liabilities (7 ) Deferred revenue (276 ) Operating lease liabilities (30 ) Net assets acquired $ 8,995 The excess of purchase price over the fair values of net tangible and intangible assets is recorded as goodwill. The fair values of tangible and identifiable intangible assets and liabilities are based on management’s estimates and assumptions. The primary intangible assets acquired were customer relationships and developed technology. The fair value estimate for customer relationships intangible asset included significant assumptions in the prospective financial information, such as revenue growth, customer attrition, EBITDA margin, and the discount rate. The fair value estimate for developed technology intangible asset included significant assumptions, including the estimate of employee hours that would be needed to recreate the technology. Additionally, these assumptions are forward looking and could be affected by future economic and market conditions. The goodwill balance is primarily attributed to the assembled workforce, additional market opportunities from offering CredentialMyDoc products, and expected synergies from integrating CredentialMyDoc with other products or other combined functional areas within the Company. The goodwill balance is deductible for U.S. income tax purposes. The net tangible assets include deferred revenue, which was adjusted down from a book value at the acquisition date of $587,000 to an estimated fair value of $276,000. The $311,000 write-down of deferred revenue will result in lower revenues than would have otherwise been recognized for such services . The following table sets forth the components of identifiable intangible assets and their estimated useful lives as of the acquisition date (in thousands): Fair value Useful life Customer relationships $ 2,100 9 years Developed technology 2,100 4 years Non-compete 110 5 years Trade name 30 3 years Total intangible assets $ 4,340 The following unaudited pro forma financial information summarizes the results of operations of the Company and CredentialMyDoc as though the companies were combined as of January 1, 2019 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Total revenues $ 60,627 $ 64,210 $ 122,330 $ 129,889 Income from continuing operations $ 3,498 $ 2,324 $ 10,690 $ 7,008 Net income $ 3,498 $ 2,324 $ 10,690 $ 8,203 Net income per share - basic $ 0.11 $ 0.07 $ 0.33 $ 0.25 Net income per share - diluted $ 0.11 $ 0.07 $ 0.33 $ 0.25 These unaudited pro forma combined results of operations include certain adjustments arising from the acquisition, such as amortization of intangible assets, depreciation of property and equipment, and fair value adjustments of acquired deferred revenue balances. The unaudited pro forma combined results of operations is for informational purposes only and is not indicative of what the Company’s results of operations would have been had the transaction occurred at the beginning of the earliest period presented or to project the Company’s results of operations in any future period. NurseGrid On March 9, 2020, the Company acquired all of the outstanding stock of HcT2 Co. dba NurseGrid (“NurseGrid”), a Portland, Oregon-based healthcare technology company offering NurseGrid Mobile and its corollary application for nurse managers, NurseGrid Enterprise, for net cash consideration of approximately $21.5 million, after giving effect to the post-closing working capital adjustment. The Company accounted for this transaction as a business combination achieved in stages which required the Company to remeasure its previously existing minority ownership interest, which was accounted for as a non-marketable equity investment measured using the fair value alternative, to fair value at the acquisition date based on the total enterprise value, adjusting for a control premium. The fair value of the Company’s interest in NurseGrid was $3.6 million at closing, resulting in a gain of $1.2 million, recorded as a change in fair value of non-marketable equity investments in the Company’s Condensed Consolidated Statements of Income. Additionally, the Company’s previously recorded non-marketable equity investment in NurseGrid was de-recognized from the Company’s Condensed Consolidated Balance Sheet. The financial results of NurseGrid have been included in the Workforce Solutions segment from March 9, 2020. A summary of the purchase price is as follows (in thousands): Cash paid at closing $ 25,485 Post-closing adjustment, net of cash received 33 Cash acquired (4,064 ) Net consideration paid 21,454 Fair value of existing equity interest in NurseGrid 3,623 Net consideration paid $ 25,077 The following table summarizes the preliminary fair value of the assets acquired and liabilities assumed as of the date of acquisition (in thousands): Accounts and unbilled receivable, net $ 92 Prepaid and other current assets 155 Operating lease right-of-use assets 50 Deferred tax assets 2,121 Goodwill 21,085 Intangible assets 1,845 Accounts payable and accrued liabilities (143 ) Deferred revenue (78 ) Operating lease liabilities (50 ) Net assets acquired $ 25,077 The excess of preliminary purchase price over the preliminary fair values of net tangible and intangible assets is recorded as goodwill. The preliminary fair values of tangible and identifiable intangible assets and liabilities are based on management’s estimates and assumptions. The primary intangible assets acquired were developed technology and trade name. The fair value estimate for developed technology intangible asset included significant assumptions, including the estimate of employee hours that would be needed to recreate the technology. The fair value estimate for trade name intangible asset included significant assumptions in the prospective financial information, such as projected revenues, royalty rate, and the discount rate. Additionally, these assumptions are forward looking and could be affected by future economic and market conditions. The preliminary fair values of assets acquired and liabilities assumed continue to be subject to change during the measurement period (up to one year from the acquisition date) as the Company finalizes the valuation of these items. The primary areas of the preliminary purchase price allocation that are not finalized include the composition and valuation of intangible assets and income tax attributes. The goodwill balance is primarily attributed to the assembled workforce, future market opportunities to engage and support the NurseGrid Mobile user community, and expected synergies from integrating NurseGrid with other combined functional areas within the Company. The goodwill balance is not deductible for U.S. income tax purposes. The net tangible assets include deferred revenue, which was adjusted down from a book value at the acquisition date of $157,000 to an estimated fair value of $78,000. The $79,000 write-down of deferred revenue will result in lower revenues than would have otherwise been recognized for such services. The following table sets forth the preliminary components of identifiable intangible assets and their estimated useful lives as of the acquisition date (in thousands): Preliminary Fair value Useful life Customer relationships $ 35 8 years Developed technology 1,110 5 years Trade name 700 Indefinite Total intangible assets $ 1,845 The amounts of revenue and operating loss of NurseGrid included in the Company’s Consolidated Statement of Income since the date of acquisition of March 9, 2020 for the three and six months ended June 30, 2020 are as follows (in thousands): Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Total revenues $ 69 $ 97 Operating loss $ (803 ) $ (1,023 ) The following unaudited pro forma financial information summarizes the results of operations of the Company and NurseGrid as though the companies were combined as of January 1, 2019 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Total revenues $ 60,588 $ 64,136 $ 122,233 $ 129,511 Income from continuing operations $ 3,469 $ 1,601 $ 9,984 $ 5,477 Net income $ 3,469 $ 1,601 $ 9,984 $ 6,671 Net income per share - basic $ 0.11 $ 0.05 $ 0.31 $ 0.21 Net income per share - diluted $ 0.11 $ 0.05 $ 0.31 $ 0.21 These unaudited pro forma combined results of operations include certain adjustments arising from the acquisition, such as amortization of intangible assets, depreciation of property and equipment, interest expense related to NurseGrid’s previously outstanding debt, and fair value adjustments of acquired deferred revenue balances . The unaudited pro forma combined results of operations is for informational purposes only and is not indicative of what the Company’s results of operations would have been had the transaction occurred at the beginning of the earliest period presented or to project the Company’s results of operations in any future period.

Business Segments

Business Segments	6 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
Business Segments	9. BUSINESS SEGMENTS The Company provides services to healthcare organizations and other members within the healthcare industry. The Company’s services are focused on the delivery of workforce development products and services (Workforce Solutions) and provider credentialing, privileging, and enrollment products and services (Provider Solutions). The Company measures segment performance based on operating income before income taxes and prior to the allocation of certain corporate overhead expenses, interest income, interest expense, and depreciation. The Unallocated component below includes corporate functions, such as accounting, human resources, legal, investor relations, administrative and executive personnel, depreciation, a portion of amortization, and certain other expenses, which are not currently allocated in measuring segment performance. Three Months Ended June 30, Six Months Ended June 30, Revenues, net: 2020 2019 2020 2019 Workforce Solutions $ 48,888 $ 52,422 $ 98,712 $ 106,716 Provider Solutions 11,665 11,359 23,413 22,251 Total revenues, net $ 60,553 $ 63,781 $ 122,125 $ 128,967 Operating income from continuing operations: Workforce Solutions $ 10,447 $ 8,890 $ 23,817 $ 20,419 Provider Solutions 1,272 1,385 2,469 2,821 Unallocated (7,415 ) (8,007 ) (14,739 ) (15,603 ) Total operating income from continuing operations $ 4,304 $ 2,268 $ 11,547 $ 7,637 Segment assets * June 30, 2020 December 31, 2019 Workforce Solutions $ 144,065 $ 118,382 Provider Solutions 141,794 148,398 Unallocated 191,966 222,764 Total assets $ 477,825 $ 489,544 * Segment assets include accounts and unbilled receivables, prepaid and other current assets, other assets, capitalized software development, certain property and equipment, goodwill, and intangible assets. Cash and cash equivalents and marketable securities are not allocated to individual segments and are included within Unallocated. A significant portion of property and equipment assets are included within Unallocated.

Discontinued Operations

Discontinued Operations	6 Months Ended
	Jun. 30, 2020
Discontinued Operations And Disposal Groups [Abstract]
Discontinued Operations	10 . DISCONTINUED OPERATIONS Patient Experience On February 12, 2018, the Company divested its PX business to Press Ganey for $65.2 million in cash (after giving effect to the post-closing working capital adjustment), resulting in a gain, net of tax, of $20.5 million, of which $19.0 million was recorded during the year ended December 31, 2018 and $1.5 million was recorded during the year ended December 31, 2019. This sale of the PX business resulted in the Company’s divestiture of the Company’s patient experience solutions business segment. The Company has classified this gain on the sale of the PX business as discontinued operations in its Condensed Consolidated Statement of Income for the six months ended June 30, 2019. Our results for the three months ended June 30, 2020 and 2019 and for the six months ended June 30, 2020 do not include any discontinued operations.

Debt

Debt	6 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Debt	11. DEBT Revolving Credit Facility On December 31, 2018, the Company entered into a Second Amendment to its Revolving Credit Agreement, dated as of November 24, 2014 (as amended, the “Revolving Credit Facility”), with SunTrust Bank (“SunTrust”), which extended the maturity date to November 24, 2020. Under the Revolving Credit Facility, the Company may borrow up to $50.0 million, which includes a $5.0 million swing line sub-facility and a $5.0 million letter of credit sub-facility, as well as an accordion feature that allows the Company to increase the Revolving Credit Facility by a total of up to $25.0 million, subject to securing additional commitments from existing lenders or new lending institutions. The obligations under the Revolving Credit Facility are guaranteed by each of the Company’s subsidiaries. At the Company’s election, the borrowings under the Revolving Credit Facility bear interest at either (1) a rate per annum equal to the highest of SunTrust’s prime rate or 0.5% in excess of the Federal Funds Rate or 1.0% in excess of one-month LIBOR (the “Base Rate”), plus an applicable margin, or (2) the one, two, three, or six month per annum LIBOR for deposits in the applicable currency (the “Eurocurrency Rate”), as selected by the Company, plus an applicable margin. The applicable margin for Eurocurrency Rate loans depends on the Company’s funded debt leverage ratio and varies from 1.50% to 2.00%. The applicable margin for Base Rate loans depends on the Company’s funded debt leverage ratio and varies from 0.50% to 1.50%. Commitment fees and letter of credit fees are also payable under the Revolving Credit Facility. Principal is payable in full at maturity on November 24, 2020, and there are no scheduled principal payments prior to maturity. The Company is required to pay a commitment fee ranging between 20 and 30 basis points per annum of the average daily unused portion of the Revolving Credit Facility, depending on the Company’s funded debt leverage ratio. The purpose of the Revolving Credit Facility is for general working capital needs, permitted acquisitions (as defined in the Revolving Credit Facility), and for stock repurchase and/or redemption transactions that the Company may authorize. The Revolving Credit Facility contains certain covenants that, among other things, restrict additional indebtedness, liens and encumbrances, changes to the character of the Company’s business, acquisitions, asset dispositions, mergers and consolidations, sale or discount of receivables, creation or acquisitions of additional subsidiaries, and other matters customarily restricted in such agreements. In addition, the Revolving Credit Facility requires the Company to meet certain financial tests, including, without limitation: • a funded debt leverage ratio (consolidated debt/consolidated EBITDA) of not greater than 3.0 to 1.0; and • an interest coverage ratio (consolidated EBITDA/consolidated interest expense) of not less than 3.0 to 1.0. As of June 30, 2020, the Company was in compliance with all covenants. There were no balances outstanding on the Revolving Credit Facility as of or during the three and six months ended June 30, 2020.

Non-Marketable Equity Investmen

Non-Marketable Equity Investments	6 Months Ended
	Jun. 30, 2020
Investments Debt And Equity Securities [Abstract]
Non-Marketable Equity Investments	12. NON-MARKETABLE EQUITY INVESTMENTS Non-marketable equity investments where the Company is not able to exercise significant influence over the investee are accounted for using the measurement alternative for equity investments that do not have readily determinable fair values. ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10) The aggregate carrying amount of all non-marketable equity investments accounted for using the measurement alternative was $2.1 million and $4.5 million as of June 30, 2020 and December 31, 2019, respectively, which carrying value we evaluate for impairment at each reporting period. cumulative upward adjustments of $ 1.2 million. These adjustments are the result of changes in fair value based on observable prices from orderly transactions for similar investments made in investees. The fair value of non-marketable equity investments is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment.

Contractual Adjustment

Contractual Adjustment	6 Months Ended
	Jun. 30, 2020
Contractual Adjustment [Abstract]
Contractual Adjustment	13. CONTRACTUAL ADJUSTMENT In June 2018, a contract with one of our royalty partners expired and was not renewed. However, the contract required continued royalty payments for any subscriptions that extended beyond the contract termination date. Following the contract termination, there was a mutual disagreement related to various elements of this past partnership, and the Company accrued but did not pay royalties to the partner following the contract expiration. During the first quarter of 2020, the Company received a release of liability from the partner associated with this contract, resulting in no royalties to be paid to the partner. The de-recognition of this royalty liability and related expense was recorded as a $3.4 million reduction to cost of revenues in the first quarter of 2020.

Recent Accounting Pronounceme_2

Recent Accounting Pronouncements (Policies)	6 Months Ended
	Jun. 30, 2020
Accounting Changes And Error Corrections [Abstract]
Accounting Standards Recently Adopted	Accounting Standards Recently Adopted In June 2016, the FASB issued ASU 2016-03, Financial Instruments—Credit Losses (“ASC 326”): Measurement of Credit Losses on Financial Instruments

Revenue Recognition and Sales_2

Revenue Recognition and Sales Commissions (Tables)	6 Months Ended
	Jun. 30, 2020
Revenue From Contract With Customer [Abstract]
Schedule of Revenues Included in Continuing Operations from Contracts with Customers Disaggregated by Revenue Source	The following table represents revenues disaggregated by revenue source for the three and six months ended June 30, 2020 and 2019 (in thousands). Sales taxes are excluded from revenues. Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Business Segments Workforce Solutions Provider Solutions Consolidated Workforce Solutions Provider Solutions Consolidated Subscription $ 47,981 $ 9,954 $ 57,935 $ 96,699 $ 19,581 $ 116,280 Professional services 907 1,711 2,618 2,013 3,832 5,845 Total revenues, net $ 48,888 $ 11,665 $ 60,553 $ 98,712 $ 23,413 $ 122,125 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Business Segments Workforce Solutions Provider Solutions Consolidated Workforce Solutions Provider Solutions Consolidated Subscription $ 50,892 $ 9,501 $ 60,393 $ 103,696 $ 18,581 $ 122,277 Professional services 1,530 1,858 3,388 3,020 3,670 6,690 Total revenues, net $ 52,422 $ 11,359 $ 63,781 $ 106,716 $ 22,251 $ 128,967

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Stock Based Compensation Expense Recognized in Condensed Consolidated Statements of Income	Total stock based compensation expense recorded for the three and six months ended June 30, 2020 and 2019, which is recorded within continuing operations in the Condensed Consolidated Statements of Income, is as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Cost of revenues (excluding depreciation and amortization) $ 16 $ 670 $ 23 $ 671 Product development 93 765 173 818 Sales and marketing 60 462 110 518 Other general and administrative 388 661 801 1,067 Total stock based compensation expense $ 557 $ 2,558 $ 1,107 $ 3,074

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2020
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2020 and 2019 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Numerator: Income from continuing operations $ 3,442 $ 2,401 $ 10,533 $ 7,181 Income from discontinued operations — — — 1,194 Net income $ 3,442 $ 2,401 $ 10,533 $ 8,375 Denominator: Weighted-average shares outstanding 31,997 32,394 32,166 32,366 Effect of dilutive shares 28 40 25 40 Weighted-average diluted shares 32,025 32,434 32,191 32,406 Net income per share - basic: Continuing operations $ 0.11 $ 0.07 $ 0.33 $ 0.22 Discontinued operations — — — 0.04 Net income per share - basic $ 0.11 $ 0.07 $ 0.33 $ 0.26 Net income per share - diluted: Continuing operations $ 0.11 $ 0.07 $ 0.33 $ 0.22 Discontinued operations — — — 0.04 Net income per share - diluted $ 0.11 $ 0.07 $ 0.33 $ 0.26

Marketable Securities (Tables)

Marketable Securities (Tables)	6 Months Ended
	Jun. 30, 2020
Investments Debt And Equity Securities [Abstract]
Fair Value of Available for Sale Marketable Securities	At June 30, 2020 and December 31, 2019, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands): June 30, 2020 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Level 2: Corporate debt securities $ 31,965 $ 36 $ (12 ) $ 31,989 Total $ 31,965 $ 36 $ (12 ) $ 31,989 December 31, 2019 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Level 2: Corporate debt securities $ 37,325 $ 7 $ (5 ) $ 37,327 Government-sponsored enterprise debt securities 4,001 — — 4,001 Total $ 41,326 $ 7 $ (5 ) $ 41,328

Business Combinations (Tables)

Business Combinations (Tables)	6 Months Ended
	Jun. 30, 2020
CredentialMyDoc [Member]
Summary of Purchase Price	A summary of the purchase price is as follows (in thousands): Cash paid at closing $ 9,000 Working capital adjustment - post-closing (5 ) Total consideration paid $ 8,995
Summary of Preliminary Fair Value of Assets Acquired and Liabilities Assumed	The following table summarizes the fair value of the assets acquired and liabilities assumed as of the date of acquisition (in thousands): Accounts and unbilled receivable, net $ 204 Prepaid and other current assets 3 Operating lease right-of-use assets 30 Deferred tax assets 70 Goodwill 4,661 Intangible assets 4,340 Accounts payable and accrued liabilities (7 ) Deferred revenue (276 ) Operating lease liabilities (30 ) Net assets acquired $ 8,995
Summary of Preliminary Components of Identifiable Intangible Assets and Estimated Useful Lives	The following table sets forth the components of identifiable intangible assets and their estimated useful lives as of the acquisition date (in thousands): Fair value Useful life Customer relationships $ 2,100 9 years Developed technology 2,100 4 years Non-compete 110 5 years Trade name 30 3 years Total intangible assets $ 4,340
Summary of Unaudited Pro Forma Financial Information	The following unaudited pro forma financial information summarizes the results of operations of the Company and CredentialMyDoc as though the companies were combined as of January 1, 2019 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Total revenues $ 60,627 $ 64,210 $ 122,330 $ 129,889 Income from continuing operations $ 3,498 $ 2,324 $ 10,690 $ 7,008 Net income $ 3,498 $ 2,324 $ 10,690 $ 8,203 Net income per share - basic $ 0.11 $ 0.07 $ 0.33 $ 0.25 Net income per share - diluted $ 0.11 $ 0.07 $ 0.33 $ 0.25
NurseGrid [Member]
Summary of Purchase Price	A summary of the purchase price is as follows (in thousands): Cash paid at closing $ 25,485 Post-closing adjustment, net of cash received 33 Cash acquired (4,064 ) Net consideration paid 21,454 Fair value of existing equity interest in NurseGrid 3,623 Net consideration paid $ 25,077
Summary of Preliminary Fair Value of Assets Acquired and Liabilities Assumed	The following table summarizes the preliminary fair value of the assets acquired and liabilities assumed as of the date of acquisition (in thousands): Accounts and unbilled receivable, net $ 92 Prepaid and other current assets 155 Operating lease right-of-use assets 50 Deferred tax assets 2,121 Goodwill 21,085 Intangible assets 1,845 Accounts payable and accrued liabilities (143 ) Deferred revenue (78 ) Operating lease liabilities (50 ) Net assets acquired $ 25,077
Summary of Preliminary Components of Identifiable Intangible Assets and Estimated Useful Lives	The following table sets forth the preliminary components of identifiable intangible assets and their estimated useful lives as of the acquisition date (in thousands): Preliminary Fair value Useful life Customer relationships $ 35 8 years Developed technology 1,110 5 years Trade name 700 Indefinite Total intangible assets $ 1,845
Summary of Unaudited Pro Forma Financial Information	The following unaudited pro forma financial information summarizes the results of operations of the Company and NurseGrid as though the companies were combined as of January 1, 2019 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Total revenues $ 60,588 $ 64,136 $ 122,233 $ 129,511 Income from continuing operations $ 3,469 $ 1,601 $ 9,984 $ 5,477 Net income $ 3,469 $ 1,601 $ 9,984 $ 6,671 Net income per share - basic $ 0.11 $ 0.05 $ 0.31 $ 0.21 Net income per share - diluted $ 0.11 $ 0.05 $ 0.31 $ 0.21
Summary of Revenue and Operating Loss Included in Company's Consolidated Statement of Income since the Date of Acquisition	The amounts of revenue and operating loss of NurseGrid included in the Company’s Consolidated Statement of Income since the date of acquisition of March 9, 2020 for the three and six months ended June 30, 2020 are as follows (in thousands): Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Total revenues $ 69 $ 97 Operating loss $ (803 ) $ (1,023 )

Business Segments (Tables)

Business Segments (Tables)	6 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
Business Segment Information Based on Net Revenues and Operating Income	The following is the Company’s business segment information for the three and six months ended June 30, 2020 and 2019 and as of June 30, 2020 and December 31, 2019 (in thousands). Three Months Ended June 30, Six Months Ended June 30, Revenues, net: 2020 2019 2020 2019 Workforce Solutions $ 48,888 $ 52,422 $ 98,712 $ 106,716 Provider Solutions 11,665 11,359 23,413 22,251 Total revenues, net $ 60,553 $ 63,781 $ 122,125 $ 128,967 Operating income from continuing operations: Workforce Solutions $ 10,447 $ 8,890 $ 23,817 $ 20,419 Provider Solutions 1,272 1,385 2,469 2,821 Unallocated (7,415 ) (8,007 ) (14,739 ) (15,603 ) Total operating income from continuing operations $ 4,304 $ 2,268 $ 11,547 $ 7,637
Business Segment Information Based on Assets	Segment assets * June 30, 2020 December 31, 2019 Workforce Solutions $ 144,065 $ 118,382 Provider Solutions 141,794 148,398 Unallocated 191,966 222,764 Total assets $ 477,825 $ 489,544 * Segment assets include accounts and unbilled receivables, prepaid and other current assets, other assets, capitalized software development, certain property and equipment, goodwill, and intangible assets. Cash and cash equivalents and marketable securities are not allocated to individual segments and are included within Unallocated. A significant portion of property and equipment assets are included within Unallocated.

Revenue Recognition and Sales_3

Revenue Recognition and Sales Commissions - Schedule of Revenues Included in Continuing Operations Disaggregated by Revenue Source (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Disaggregation Of Revenue [Line Items]
Total revenues, net	$ 60,553	$ 63,781	$ 122,125	$ 128,967
Workforce Solutions [Member]
Disaggregation Of Revenue [Line Items]
Total revenues, net	48,888	52,422	98,712	106,716
Provider Solutions [Member]
Disaggregation Of Revenue [Line Items]
Total revenues, net	11,665	11,359	23,413	22,251
Subscription Services [Member]
Disaggregation Of Revenue [Line Items]
Total revenues, net	57,935	60,393	116,280	122,277
Subscription Services [Member] | Workforce Solutions [Member]
Disaggregation Of Revenue [Line Items]
Total revenues, net	47,981	50,892	96,699	103,696
Subscription Services [Member] | Provider Solutions [Member]
Disaggregation Of Revenue [Line Items]
Total revenues, net	9,954	9,501	19,581	18,581
Professional Services [Member]
Disaggregation Of Revenue [Line Items]
Total revenues, net	2,618	3,388	5,845	6,690
Professional Services [Member] | Workforce Solutions [Member]
Disaggregation Of Revenue [Line Items]
Total revenues, net	907	1,530	2,013	3,020
Professional Services [Member] | Provider Solutions [Member]
Disaggregation Of Revenue [Line Items]
Total revenues, net	$ 1,711	$ 1,858	$ 3,832	$ 3,670

Revenue Recognition and Sales_4

Revenue Recognition and Sales Commissions - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue Recognition and Sales Commissions [Line Items]
Revenues recognized in period, included in deferred revenue at beginning of the period	$ 35,200,000	$ 36,300,000	$ 49,900,000	$ 51,200,000
Estimated revenue expected to be recognized in future under contract with customers	380,000,000		$ 380,000,000
Description of sales commission plan			Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer. The sales commission plan for 2020 typically includes two payments; the initial payment is due in the period a customer contract is entered into, and the final payment is due 60 days after the product implementation is completed. The sales commission plan for 2019 typically included an initial payment in the period a customer contract was entered into, and subsequent payments either 15 or 27 months after the initial payment, depending on the contract term.
Sales Commissions, amortization term description			Non-commensurate commissions are amortized over the greater of the contract term or technological obsolescence period of approximately three years.
Sales Commissions, amortization period			3 years
Amortization of deferred commissions	2,100,000	2,100,000	$ 4,254,000	4,201,000
Customer Contracts [Member]
Revenue Recognition and Sales Commissions [Line Items]
Impairment losses on receivables and contract asset	$ 63,000	$ 46,000	$ 351,000	$ 48,000

Revenue Recognition and Sales_5

Revenue Recognition and Sales Commissions - Additional Information (Detail 1) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-07-01	Jun. 30, 2020
Revenue Recognition and Sales Commissions [Line Items]
Percentage of remaining performance obligations expects revenue	45.00%
Estimated revenue, expected recognition period	12 months

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Income tax provision	$ 1,061,000	$ 719,000	$ 2,920,000	$ 2,130,000
Effective tax rate for continuing operations			22.00%	23.00%
Additional income tax expense for tax deficiencies associated with stock based awards			$ 26,000
Reduction in income tax expense for excess tax benefits associated with stock based awards				$ 123,000

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Detail)	Mar. 13, 2020USD ($)	Jun. 30, 2019shares	Jun. 26, 2019USD ($)Employeeshares	Jun. 30, 2019USD ($)	Jun. 30, 2020USD ($)$ / sharesshares	Mar. 31, 2020USD ($)	Jun. 30, 2019USD ($)	Jun. 30, 2020USD ($)$ / sharesshares	Jun. 30, 2019USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount	$ 30,000,000
Stock repurchase program, termination date	Mar. 12, 2021
Share repurchased, shares | shares					5,799			443,941
Share repurchased, fair value					$ 133,000	$ 9,876,000		$ 10,000,000
Share repurchased, average price per share | $ / shares					$ 22.87			$ 22.53
Stock based compensation expense					$ 557,000		$ 2,558,000	$ 1,107,000	$ 3,074,000
Payments related to employees' tax obligations to taxing authorities for stock awards									$ 600,000
Employer tax and expenses for stock awards				$ 200,000
Chief Executive Officer, Robert A. Frist, Jr., [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares contributed to the company | shares			78,520
Value of shares contributed to the company			$ 2,000,000
Number of additional shares contributed to the company | shares		7,852
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted share units issued | shares								111,510	86,220
Weighted average grant date fair value, restricted share unit | $ / shares								$ 22.96	$ 27.39
2016 Omnibus Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vested | shares			78,520
Number of employees awarded fully vested shares | Employee			820
Stock based compensation expense							$ 2,000,000

Shareholders' Equity - Stock Ba

Shareholders' Equity - Stock Based Compensation Expense Recognized in Condensed Consolidated Statements of Income (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock based compensation expense	$ 557	$ 2,558	$ 1,107	$ 3,074
Cost of Revenues (Excluding Depreciation and Amortization) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock based compensation expense	16	670	23	671
Product Development [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock based compensation expense	93	765	173	818
Sales and Marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock based compensation expense	60	462	110	518
Other General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock based compensation expense	$ 388	$ 661	$ 801	$ 1,067

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Earnings Per Share [Abstract]
Total number of common equivalent shares excluded from the calculations of diluted earnings per share	108,000	131,000	107,000	134,000

Earnings Per Share - Computatio

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019
Numerator:
Income from continuing operations	$ 3,442		$ 2,401		$ 10,533	$ 7,181
Income from discontinued operations						1,194
Net income	$ 3,442	$ 7,092	$ 2,401	$ 5,974	$ 10,533	$ 8,375
Denominator:
Weighted-average shares outstanding	31,997		32,394		32,166	32,366
Effect of dilutive shares	28		40		25	40
Weighted-average diluted shares	32,025		32,434		32,191	32,406
Net income per share – basic:
Continuing operations	$ 0.11		$ 0.07		$ 0.33	$ 0.22
Discontinued operations						0.04
Net income per share - basic	0.11		0.07		0.33	0.26
Net income per share - diluted:
Continuing operations	0.11		0.07		0.33	0.22
Discontinued operations						0.04
Net income per share - diluted	$ 0.11		$ 0.07		$ 0.33	$ 0.26

Marketable Securities - Fair Va

Marketable Securities - Fair Value of Available for Sale Marketable Securities (Detail) - Level 2 [Member] - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	$ 31,965	$ 41,326
Available for sale securities, Unrealized Gains	36	7
Available for sale securities, Unrealized Losses	(12)	(5)
Available for sale securities, Fair Value	31,989	41,328
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	31,965	37,325
Available for sale securities, Unrealized Gains	36	7
Available for sale securities, Unrealized Losses	(12)	(5)
Available for sale securities, Fair Value	$ 31,989	37,327
Government-Sponsored Enterprises Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost		4,001
Available for sale securities, Fair Value		$ 4,001

Marketable Securities - Additio

Marketable Securities - Additional Information (Detail)	Jun. 30, 2020USD ($)
Amortized Cost And Fair Value Debt Securities [Abstract]
Available for sale debt securities, allowance for credit impairments	$ 0

Business Combinations - Additio

Business Combinations - Additional Information (Detail) - USD ($)	Mar. 09, 2020	Dec. 16, 2019
CredentialMyDoc [Member]
Business Acquisition [Line Items]
Consideration paid for acquisition in cash		$ 8,995,000
Net tangible assets include deferred revenue book value at acquisition date		587,000
Net tangible assets include deferred revenue fair value at acquisition date		276,000
Write-down of deferred revenue		311,000
CredentialMyDoc [Member] | Recovery of Working Capital Adjustment and Certain Potential Indemnification Claims [Member]
Business Acquisition [Line Items]
Purchase price held in escrow		$ 1,100,000
NurseGrid [Member]
Business Acquisition [Line Items]
Consideration paid for acquisition in cash	$ 21,500,000
Net tangible assets include deferred revenue book value at acquisition date	157,000
Net tangible assets include deferred revenue fair value at acquisition date	78,000
Write-down of deferred revenue	79,000
Fair value of existing equity interest	3,623,000
Gain recognized from remeasurement of equity interest	$ 1,200,000
NurseGrid [Member] | Maximum [Member]
Business Acquisition [Line Items]
Preliminary purchase price allocation measurement period from acquisition date	1 year

Business Combinations - Summary

Business Combinations - Summary of Purchase Price (Detail) - USD ($) $ in Thousands	Mar. 09, 2020	Dec. 16, 2019
CredentialMyDoc [Member]
Business Acquisition [Line Items]
Total consideration paid		$ 8,995
CredentialMyDoc [Member] | Cash Paid at Closing [Member]
Business Acquisition [Line Items]
Total consideration paid		9,000
CredentialMyDoc [Member] | Working Capital Adjustment - Post-Closing [Member]
Business Acquisition [Line Items]
Total consideration paid		$ (5)
NurseGrid [Member]
Business Acquisition [Line Items]
Total consideration paid	$ 21,500
Cash acquired	(4,064)
Net consideration paid	21,454
Fair value of existing equity interest in NurseGrid	3,623
Net consideration paid	25,077
NurseGrid [Member] | Cash Paid at Closing [Member]
Business Acquisition [Line Items]
Total consideration paid	25,485
NurseGrid [Member] | Post-closing Adjustment, Net of Cash Received [Member]
Business Acquisition [Line Items]
Total consideration paid	$ 33

Business Combinations - Summa_2

Business Combinations - Summary of Preliminary Fair Value of Assets Acquired and Liabilities Assumed (Detail) - USD ($)	Jun. 30, 2020	Mar. 09, 2020	Dec. 31, 2019	Dec. 16, 2019
Business Acquisition [Line Items]
Goodwill	$ 123,285,000		$ 102,196,000
CredentialMyDoc [Member]
Business Acquisition [Line Items]
Accounts and unbilled receivable, net				$ 204,000
Prepaid and other current assets				3,000
Operating lease right-of-use assets				30,000
Deferred tax assets				70,000
Goodwill				4,661,000
Intangible assets				4,340,000
Accounts payable and accrued liabilities				(7,000)
Deferred revenue				(276,000)
Operating lease liabilities				(30,000)
Net assets acquired				$ 8,995,000
NurseGrid [Member]
Business Acquisition [Line Items]
Accounts and unbilled receivable, net		$ 92,000
Prepaid and other current assets		155,000
Operating lease right-of-use assets		50,000
Deferred tax assets		2,121,000
Goodwill		21,085,000
Intangible assets		1,845,000
Accounts payable and accrued liabilities		(143,000)
Deferred revenue		(78,000)
Operating lease liabilities		(50,000)
Net assets acquired		$ 25,077,000

Business Combinations - Summa_3

Business Combinations - Summary of Preliminary Components of Identifiable Intangible Assets and Estimated Useful Lives (Detail) - USD ($) $ in Thousands	Mar. 09, 2020	Dec. 16, 2019
CredentialMyDoc [Member]
Business Acquisition [Line Items]
Preliminary Fair value		$ 4,340
CredentialMyDoc [Member] | Customer Relationships [Member]
Business Acquisition [Line Items]
Preliminary Fair value		$ 2,100
Useful life		9 years
CredentialMyDoc [Member] | Developed Technology [Member]
Business Acquisition [Line Items]
Preliminary Fair value		$ 2,100
Useful life		4 years
CredentialMyDoc [Member] | Non-Compete [Member]
Business Acquisition [Line Items]
Preliminary Fair value		$ 110
Useful life		5 years
CredentialMyDoc [Member] | Trade Name [Member]
Business Acquisition [Line Items]
Preliminary Fair value		$ 30
Useful life		3 years
NurseGrid [Member]
Business Acquisition [Line Items]
Preliminary Fair value	$ 1,845
NurseGrid [Member] | Customer Relationships [Member]
Business Acquisition [Line Items]
Preliminary Fair value	$ 35
Useful life	8 years
NurseGrid [Member] | Developed Technology [Member]
Business Acquisition [Line Items]
Preliminary Fair value	$ 1,110
Useful life	5 years
NurseGrid [Member] | Trade Name [Member]
Business Acquisition [Line Items]
Preliminary Fair value	$ 700

Business Combinations - Summa_4

Business Combinations - Summary of Unaudited Pro Forma Financial Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
CredentialMyDoc [Member]
Business Acquisition [Line Items]
Total revenues	$ 60,627	$ 64,210	$ 122,330	$ 129,889
Income from continuing operations	3,498	2,324	10,690	7,008
Net income	$ 3,498	$ 2,324	$ 10,690	$ 8,203
Net income per share - basic	$ 0.11	$ 0.07	$ 0.33	$ 0.25
Net income per share - diluted	$ 0.11	$ 0.07	$ 0.33	$ 0.25
NurseGrid [Member]
Business Acquisition [Line Items]
Total revenues	$ 60,588	$ 64,136	$ 122,233	$ 129,511
Income from continuing operations	3,469	1,601	9,984	5,477
Net income	$ 3,469	$ 1,601	$ 9,984	$ 6,671
Net income per share - basic	$ 0.11	$ 0.05	$ 0.31	$ 0.21
Net income per share - diluted	$ 0.11	$ 0.05	$ 0.31	$ 0.21

Business Combinations - Summa_5

Business Combinations - Summary of Revenue and Operating Loss Included in Company's Consolidated Statement of Income since the Date of Acquisition (Detail) - NurseGrid [Member] - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2020
Business Acquisition [Line Items]
Total revenues	$ 69	$ 97
Operating loss	$ (803)	$ (1,023)

Business Segments - Business Se

Business Segments - Business Segment Information Based on Net Revenues and Operating Income (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues, net:
Revenues, net	$ 60,553	$ 63,781	$ 122,125	$ 128,967
Operating income from continuing operations:
Operating income from continuing operations	4,304	2,268	11,547	7,637
Workforce Solutions [Member]
Revenues, net:
Revenues, net	48,888	52,422	98,712	106,716
Provider Solutions [Member]
Revenues, net:
Revenues, net	11,665	11,359	23,413	22,251
Operating Segments [Member] | Workforce Solutions [Member]
Revenues, net:
Revenues, net	48,888	52,422	98,712	106,716
Operating income from continuing operations:
Operating income from continuing operations	10,447	8,890	23,817	20,419
Operating Segments [Member] | Provider Solutions [Member]
Revenues, net:
Revenues, net	11,665	11,359	23,413	22,251
Operating income from continuing operations:
Operating income from continuing operations	1,272	1,385	2,469	2,821
Unallocated [Member]
Operating income from continuing operations:
Operating income from continuing operations	$ (7,415)	$ (8,007)	$ (14,739)	$ (15,603)

Business Segments - Business _2

Business Segments - Business Segment Information Based on Assets (Detail) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Total assets	$ 477,825	$ 489,544
Operating Segments [Member] | Workforce Solutions [Member]
Segment Reporting Information [Line Items]
Total assets	144,065	118,382
Operating Segments [Member] | Provider Solutions [Member]
Segment Reporting Information [Line Items]
Total assets	141,794	148,398
Unallocated [Member]
Segment Reporting Information [Line Items]
Total assets	$ 191,966	$ 222,764

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Detail) - Patient Experience Solutions [Member] - USD ($) $ in Millions	Feb. 12, 2018	Dec. 31, 2019	Dec. 31, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Consideration received	$ 65.2
Gain on sale of business, net of tax	$ 20.5	$ 1.5	$ 19

Debt - Additional Information (

Debt - Additional Information (Detail) - SunTrust Bank [Member]	6 Months Ended
	Jun. 30, 2020USD ($)
Line of Credit Facility [Line Items]
Description of Line of credit facility Covenant	• a funded debt leverage ratio (consolidated debt/consolidated EBITDA) of not greater than 3.0 to 1.0; and • an interest coverage ratio (consolidated EBITDA/consolidated interest expense) of not less than 3.0 to 1.0.
Minimum [Member]
Line of Credit Facility [Line Items]
Commitment fee paid per annum	0.20%
Maximum [Member]
Line of Credit Facility [Line Items]
Commitment fee paid per annum	0.30%
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Maturity date of Loan agreement	Nov. 24, 2020
Interest rate under credit facility	the borrowings under the Revolving Credit Facility bear interest at either (1) a rate per annum equal to the highest of SunTrust’s prime rate or 0.5% in excess of the Federal Funds Rate or 1.0% in excess of one-month LIBOR (the “Base Rate”), plus an applicable margin, or (2) the one, two, three, or six month per annum LIBOR for deposits in the applicable currency (the “Eurocurrency Rate”), as selected by the Company, plus an applicable margin. The applicable margin for Eurocurrency Rate loans depends on the Company’s funded debt leverage ratio and varies from 1.50% to 2.00%. The applicable margin for Base Rate loans depends on the Company’s funded debt leverage ratio and varies from 0.50% to 1.50%
Maximum borrowing capacity under credit facility	$ 50,000,000
Increase in revolving credit facility	25,000,000
Principal payments prior to maturity	0
Outstanding balance on revolving credit facility	0
Revolving Credit Facility [Member] | Swing Line Sub Facility [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity under credit facility	5,000,000
Revolving Credit Facility [Member] | Letter of Credit Subfacility [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity under credit facility	$ 5,000,000
Revolving Credit Facility [Member] | Federal Funds Effective Swap Rate [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Interest Rate During Period	0.50%
Revolving Credit Facility [Member] | Base Rate [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Interest Rate During Period	1.00%
Revolving Credit Facility [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Interest coverage ratio	300.00%
Revolving Credit Facility [Member] | Minimum [Member] | Base Rate [Member]
Line of Credit Facility [Line Items]
Applicable margin for loans	0.50%
Revolving Credit Facility [Member] | Minimum [Member] | Eurodollar [Member]
Line of Credit Facility [Line Items]
Applicable margin for loans	1.50%
Revolving Credit Facility [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Debt leverage ratio	300.00%
Revolving Credit Facility [Member] | Maximum [Member] | Base Rate [Member]
Line of Credit Facility [Line Items]
Applicable margin for loans	1.50%
Revolving Credit Facility [Member] | Maximum [Member] | Eurodollar [Member]
Line of Credit Facility [Line Items]
Applicable margin for loans	2.00%

Non-Marketable Equity Investm_2

Non-Marketable Equity Investments - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 09, 2020	Jun. 30, 2020	Dec. 31, 2018	Dec. 31, 2019
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Aggregate carrying amount of non-marketable equity investments		$ 2,100		$ 4,500
Changes in adjustment to carrying value of non-marketable equity investment due to change in fair value		(1,181)	$ 1,300
Cumulative downward adjustments to carrying value of non-marketable equity investments		$ 100
NurseGrid [Member]
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Changes in adjustment to carrying value of non-marketable equity investment due to change in fair value	$ 1,200

Contractual Adjustment - Additi

Contractual Adjustment - Additional Information (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)
Contractual Adjustment [Abstract]
Cost of goods and services sold, derecognized	$ 3.4